Morgan Stanley cuts India's GlaxoSmithKline Pharma to 'under-weight'
Reuters | HT Correspondent, Mumbai
Feb 28, 2013 10:25 AM IST
Morgan Stanley cut its rating on India's GlaxoSmithKline Pharmaceuticals Ltd to "under-weight" from "equal-weight", citing expectations the drug maker will post modest growth and saying margin expansion looked unlikely.
Morgan Stanley cut its rating on India's GlaxoSmithKline Pharmaceuticals Ltd to "under-weight" from "equal-weight", citing expectations the drug maker will post modest growth and saying margin expansion looked unlikely.
GlaxoSmithKline's shares are also constrained by its pricing policy and "full" valuations, the broker added.
Hindustan Times - your fastest source for breaking news! Read now.
Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away!- Login Now!
Stay informed on Business News along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs
Stay informed on Business News along with Gold Rates Today, India News and other related updates on Hindustan Times Website and APPs
Share this article